Cita APA

Martin, S. M., Churchill, E., McKnight, H., Mahaffey, C. M., Ma, Y., O'Donnell, R. T., & Tuscano, J. M. (2011). The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner. BioMed Central.

Citación estilo Chicago

Martin, Shiloh M., Eric Churchill, Hayes McKnight, Christopher M. Mahaffey, Yunpeng Ma, Robert T. O'Donnell, y Joseph M. Tuscano. The HB22.7 Anti-CD22 Monoclonal Antibody Enhances Bortezomib-mediated Lymphomacidal Activity in a Sequence Dependent Manner. BioMed Central, 2011.

Cita MLA

Martin, Shiloh M., et al. The HB22.7 Anti-CD22 Monoclonal Antibody Enhances Bortezomib-mediated Lymphomacidal Activity in a Sequence Dependent Manner. BioMed Central, 2011.